Title | Type | SJR | H index | Total Docs. (2014) | Total Docs. (3years) | Total Refs. (2014) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2014) | %Female (2014) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
51 | Biological and Pharmaceutical Bulletin | journal | 0.774 Q2 | 134 | 291 | 985 | 9325 | 2219 | 968 | 2.09 | 32.04 | 31.43 | |
52 | Drug Resistance Updates | journal | 3.578 Q1 | 132 | 9 | 63 | 904 | 687 | 59 | 10.06 | 100.44 | 34.21 | |
53 | Cancer Biology and Therapy | journal | 1.688 Q1 | 130 | 193 | 584 | 7556 | 2160 | 523 | 3.24 | 39.15 | 40.37 | |
54 | European Neuropsychopharmacology | journal | 2.209 Q1 | 130 | 192 | 403 | 10696 | 2152 | 382 | 4.43 | 55.71 | 40.93 | |
55 | Journal of Clinical Pharmacology | journal | 0.997 Q2 | 130 | 170 | 558 | 4423 | 1539 | 525 | 2.74 | 26.02 | 36.05 | |
56 | Apoptosis : an international journal on programmed cell death | journal | 1.583 Q1 | 128 | 143 | 348 | 7421 | 1402 | 346 | 3.91 | 51.90 | 37.52 | |
57 | International Journal of Neuropsychopharmacology | journal | 1.924 Q1 | 125 | 219 | 445 | 12164 | 2061 | 433 | 4.27 | 55.54 | 39.37 | |
58 | Fitoterapia | journal | 0.897 Q2 | 124 | 266 | 700 | 8676 | 2095 | 698 | 2.84 | 32.62 | 37.99 | |
59 | European Journal of Clinical Pharmacology | journal | 1.198 Q1 | 123 | 183 | 666 | 6745 | 2109 | 569 | 3.15 | 36.86 | 43.69 | |
60 | Cancer Chemotherapy and Pharmacology | journal | 1.141 Q1 | 122 | 285 | 960 | 8854 | 3092 | 938 | 3.35 | 31.07 | 30.68 | |
61 | Current Drug Metabolism | journal | 1.014 Q2 | 122 | 70 | 329 | 8760 | 1127 | 291 | 3.23 | 125.14 | 37.41 | |
62 | ChemMedChem | journal | 1.110 | 119 | 320 | 688 | 12177 | 1932 | 668 | 2.76 | 38.05 | 35.72 | |
63 | Current Drug Targets | journal | 1.395 Q1 | 119 | 118 | 561 | 12855 | 1973 | 508 | 3.19 | 108.94 | 33.48 | |
64 | PharmacoEconomics | journal | 1.203 Q1 | 118 | 108 | 270 | 4933 | 708 | 232 | 2.49 | 45.68 | 35.40 | |
65 | Acta Pharmacologica Sinica | journal | 1.054 Q2 | 117 | 163 | 586 | 5725 | 1508 | 571 | 2.66 | 35.12 | 44.71 | |
66 | Expert Opinion on Investigational Drugs | journal | 1.431 Q1 | 117 | 140 | 442 | 11529 | 1741 | 434 | 4.18 | 82.35 | 39.36 | |
67 | Journal for ImmunoTherapy of Cancer | journal | 0.486 Q3 | 117 | 42 | 21 | 1801 | 47 | 20 | 2.24 | 42.88 | 34.11 | |
68 | Clinical and Experimental Pharmacology and Physiology | journal | 1.042 Q2 | 115 | 132 | 423 | 5878 | 1007 | 366 | 2.36 | 44.53 | 42.25 | |
69 | Steroids | journal | 0.889 Q2 | 114 | 173 | 593 | 8211 | 1701 | 584 | 2.83 | 47.46 | 41.21 | |
70 | Journal of Cardiovascular Pharmacology | journal | 0.992 Q2 | 109 | 142 | 476 | 6654 | 1169 | 456 | 2.27 | 46.86 | 31.97 | |
71 | Anti-Cancer Agents in Medicinal Chemistry | journal | 0.963 Q2 | 108 | 144 | 409 | 11251 | 1144 | 375 | 2.65 | 78.13 | 40.47 | |
72 | Vascular Pharmacology | journal | 1.577 Q1 | 108 | 74 | 179 | 4003 | 723 | 164 | 4.01 | 54.09 | 43.47 | |
73 | American Journal of Health-System Pharmacy | journal | 0.630 Q2 | 107 | 345 | 1066 | 5198 | 1299 | 604 | 1.22 | 15.07 | 49.69 | |
74 | Inflammation Research | journal | 0.935 Q2 | 107 | 108 | 410 | 4553 | 1016 | 405 | 2.54 | 42.16 | 40.97 | |
75 | Mini-Reviews in Medicinal Chemistry | journal | 0.769 Q2 | 107 | 95 | 412 | 8756 | 1381 | 393 | 3.20 | 92.17 | 45.98 | |
76 | Environmental Toxicology and Pharmacology | journal | 0.693 Q2 | 106 | 252 | 504 | 11239 | 1281 | 504 | 2.45 | 44.60 | 41.19 | |
77 | Expert Opinion on Therapeutic Targets | journal | 1.990 Q1 | 106 | 116 | 380 | 11340 | 1797 | 367 | 4.78 | 97.76 | 38.19 | |
78 | Journal of Immunotherapy | journal | 1.730 Q1 | 106 | 52 | 204 | 1909 | 859 | 196 | 4.34 | 36.71 | 38.56 | |
79 | Expert Review of Vaccines | journal | 1.533 Q1 | 105 | 167 | 459 | 14550 | 1767 | 393 | 3.85 | 87.13 | 42.92 | |
80 | Basic and Clinical Pharmacology and Toxicology | journal | 0.747 Q2 | 103 | 152 | 398 | 6131 | 954 | 380 | 2.41 | 40.34 | 40.85 | |
81 | Current Cancer Drug Targets | journal | 1.533 Q1 | 103 | 65 | 265 | 6080 | 1029 | 246 | 3.86 | 93.54 | 35.97 | |
82 | Current Neuropharmacology | journal | 1.212 Q1 | 103 | 44 | 177 | 5733 | 573 | 168 | 3.30 | 130.30 | 39.57 | |
83 | Anti-Cancer Drugs | journal | 0.744 Q2 | 102 | 148 | 397 | 5845 | 859 | 388 | 2.06 | 39.49 | 37.30 | |
84 | Expert Opinion on Biological Therapy | journal | 1.326 Q1 | 102 | 162 | 487 | 11723 | 1875 | 476 | 3.97 | 72.36 | 35.19 | |
85 | Therapeutic Drug Monitoring | journal | 0.719 Q2 | 102 | 129 | 348 | 3606 | 822 | 309 | 2.31 | 27.95 | 38.52 | |
86 | Experimental and Clinical Psychopharmacology | journal | 1.477 Q1 | 101 | 61 | 155 | 3142 | 501 | 153 | 3.05 | 51.51 | 41.05 | |
87 | Journal of Pharmacological Sciences | journal | 0.949 Q2 | 101 | 149 | 437 | 6116 | 1086 | 436 | 2.49 | 41.05 | 29.89 | |
88 | Drug Development and Industrial Pharmacy | journal | 0.783 Q2 | 100 | 196 | 555 | 7896 | 1198 | 546 | 2.09 | 40.29 | 36.73 | |
89 | Expert Opinion on Drug Metabolism and Toxicology | journal | 0.906 Q2 | 100 | 127 | 375 | 11853 | 1234 | 373 | 3.30 | 93.33 | 36.29 | |
90 | Journal of AOAC International | journal | 0.446 Q3 | 100 | 229 | 657 | 5836 | 861 | 644 | 1.25 | 25.48 | 39.81 | |
91 | Pharmacogenomics | journal | 0.965 Q2 | 100 | 193 | 606 | 9357 | 1578 | 506 | 2.35 | 48.48 | 42.57 | |
92 | Naunyn-Schmiedeberg's Archives of Pharmacology | journal | 0.900 Q2 | 99 | 136 | 341 | 5540 | 845 | 334 | 2.45 | 40.74 | 42.05 | |
93 | Pharmacological Reports | journal | 0.747 Q2 | 98 | 165 | 488 | 7048 | 1149 | 486 | 2.22 | 42.72 | 48.90 | |
94 | Bulletin of Mathematical Biology | journal | 0.659 Q2 | 97 | 120 | 366 | 4815 | 575 | 358 | 1.49 | 40.13 | 32.32 | |
95 | Investigational New Drugs | journal | 1.093 Q1 | 97 | 142 | 622 | 4435 | 2010 | 618 | 3.27 | 31.23 | 35.68 | |
96 | CNS and Neurological Disorders - Drug Targets | journal | 1.070 Q1 | 96 | 196 | 362 | 18231 | 990 | 313 | 2.50 | 93.02 | 38.01 | |
97 | Canadian Journal of Physiology and Pharmacology | journal | 0.719 Q2 | 95 | 159 | 429 | 7526 | 828 | 412 | 2.05 | 47.33 | 41.68 | |
98 | Pharmacogenomics Journal | journal | 1.648 Q1 | 95 | 78 | 187 | 3479 | 930 | 187 | 4.76 | 44.60 | 38.31 | |
99 | Drug Design, Development and Therapy | journal | 1.034 Q2 | 94 | 235 | 227 | 10969 | 872 | 227 | 3.52 | 46.68 | 37.12 | |
100 | Addiction Biology | journal | 2.194 Q1 | 93 | 101 | 260 | 4998 | 1376 | 257 | 5.48 | 49.49 | 37.40 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®